← Back to Clinical Trials
Recruiting NCT06891092

Vivinex Impress XY1-EM vs RayOne EMV

Trial Parameters

Condition Cataract
Sponsor Medical University of Bialystok
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex ALL
Min Age 21 Years
Max Age 80 Years
Start Date 2026-01-01
Completion 2027-06-01
Interventions
RayOne EMVVivinex Impress

Brief Summary

Comparison of the outcomes of bilateral implantation of extended depth of vision (EDOF) intraocular lenses (IOLs): the Rayone EMV and the Vivinex Impress XY1-EM in patients with cataract

Eligibility Criteria

Inclusion Criteria: * age-related bilateral cataract * age 21 or older * visual acuity \> 0.05 * axial length: 22.0 - 26.0 mm * normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant * written informed consent prior to surgery Exclusion Criteria: * active ocular disease (e.g. chronic severe uveitis, proliferative diabetic retinopathy, chronic glaucoma not responsive to medication) * relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX), intraoperative floppy iris syndrome (IFIS) * corneal decompensation or corneal endothelial cell insufficiency * previous ocular surgery or trauma * persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age) * corneal astigmatism \> 1 dpt. * retinopathies

Related Trials